Author Information
Juan Luis Tamargo is a distinguished researcher affiliated with the Department of Pharmacology at the School of Medicine, Universidad Complutense. Additionally, he is associated with the Instituto de Investigación Sanitaria Gregorio Marañón and CIBERCV in Madrid, Spain. His expertise in pharmacology, particularly in the context of cardiovascular diseases, is well-recognized in the scientific community.Research Contributions
Juan Luis Tamargo's research primarily focuses on pharmacotherapy in cardiovascular diseases, with a particular emphasis on cardiotoxicity, atrial fibrillation, and pharmacogenomics. His recent work includes examining the cardiotoxic effects of cancer chemotherapy, the role of calcium channel blockers and beta-blockers in heart conditions, and the challenges of polypharmacy in older populations with cardiovascular disease. His contributions provide valuable insights into the management and therapeutic strategies for cardiovascular patients, especially those with complex conditions like COVID-19 and cancer.Aliases
Throughout his career, Juan Luis Tamargo has been cited under various aliases including Juan L. Tamargo, J. L. Tamargo, and J. Tamargo, among others. This variation in names is common in academic publishing and reflects different formats or preferences in name presentation across publications and collaborations.Publication and Citation Metrics
| Metric |
Value |
| Total Citations |
58,306 |
| h-index |
78 |
| Total Papers |
494 |
